This content is from: Premium
Life Sciences Funds Continue to Struggle in 2022
Most were down by double-digits in the first quarter.
Life sciences hedge funds picked up in the first quarter where they left off last year.And that’s not a good thing.Many of them not only lost money for the three-month period, they suffered another round of double-digit losses following last year’s disastrous declines.The life sciences hedge funds are victims of
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.